Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2023 Annual Meeting | C194 - Alzheimer's Disease

Thursday 04/27/23
01:00 PM - 03:00 PM EST Add To Calendar
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Seminar
Liliana A. Ramirez-Gomez, MD
Aging, Dementia, Cognitive, and Behavioral Neurology
Participants will be introduced to the concept of AD as a clinicopathologic entity and explain approaches to detect AD early in the disease continuum; discuss the range of biomarker breakthroughs to detect AD, including blood base, CSF, and neuroimaging biomarkers, and the role of these tools in research and clinical practice; discuss the importance of integrating clinical assessment and biomarkers to obtain an early diagnosis; recognize and understand the clinical heterogeneity in AD; discuss the most recent therapeutic advances and emerging therapies for Alzheimer's disease; and discuss the Appropriate Use Recommendations for monoclonal antibodies. Considerations on how to achieve equity in dementia care and research will also be discussed.

This program is supported in part by an educational grant from Eisai, Inc.

The Academy was solely responsible, with no influence from the industry supporter, for selection of content, format, presenters, and moderators of this CME program, and the speakers have not been contacted or influenced in any way by the industry supporter with regard to this CME program.
2.00 CME credits
Patient Care & Procedural Skills, Medical Knowledge
Introductory
Diversity, Equity, and Inclusion, Advanced Practice Provider
Fellow, Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider
Didactic, Audience Participation

Program Materials Program Evaluations

Event Timeline
01:00 PM - 01:05 PM EST Introduction Welcome and Introductions
Liliana A. Ramirez-Gomez, MD
01:05 PM - 01:40 PM EST Speaker Diagnosis of Alzheimer's Disease in the Era of In Vivo Biomarkers
Jasmeer Chhatwal, MD, PhD
01:40 PM - 02:15 PM EST Speaker Monoclonal Antibodies for the Treatment of Alzheimer's Disease
Jeremy J. Pruzin, MD
02:15 PM - 02:45 PM EST Speaker Towards Achieving Equity in Dementia Care and Research
Liliana A. Ramirez-Gomez, MD
02:45 PM - 03:00 PM EST Discussion Questions and Answers
Liliana A. Ramirez-Gomez, MD, Jasmeer Chhatwal, MD, PhD, Jeremy J. Pruzin, MD
Faculty Disclosures
Liliana A. Ramirez-Gomez, MD The institution of Dr. Ramirez-Gomez has received research support from NIA-NIH.
Jasmeer Chhatwal, MD, PhD Dr. Chhatwal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ExpertConnect. Dr. Chhatwal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Humana Healthcare.
Jeremy J. Pruzin, MD Dr. Pruzin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Gila County Counsel on Aging. The institution of Dr. Pruzin has received research support from Alzheimer's Association. The institution of Dr. Pruzin has received research support from NIA.